Polarean Imaging plc (POLX.L)
| Previous close | 1.8400 |
| Open | 1.8950 |
| Bid | 1.6500 x 0 |
| Ask | 1.7000 x 0 |
| Day's range | 1.6250 - 1.9750 |
| 52-week range | 0.8529 - 26.0000 |
| Volume | |
| Avg. volume | 14,505,283 |
| Market cap | 19.916M |
| Beta (5Y monthly) | 0.56 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | N/A |
- GlobeNewswire
Polarean Raises $12.6 Million in Oversubscribed Financing Round to Accelerate XENOVIEW™ Commercialization and Strategic Growth Initiatives
Financing led by existing and new investors DURHAM, NC and LONDON, June 20, 2024 (GLOBE NEWSWIRE) -- Polarean Imaging plc (AIM: POLX) (“Polarean” or the “Company”), a commercial-stage medical device leader in advanced Magnetic Resonance Imaging (MRI) of the lungs, announces the closing of a $12.6 million oversubscribed financing via the Alternative Investment Market (AIM) of the London Stock Exchange. The fundraise was co-led by strategic investors NUKEM Isotopes GmbH and Bracco S.p.A., in addit
- GlobeNewswire
Polarean’s Xenon MRI to be Featured at Upcoming ATS 2024 Conference
Featured Company at Respiratory Innovation Summit to Jump Start Robust PresenceDURHAM, NC and LONDON, May 08, 2024 (GLOBE NEWSWIRE) -- Polarean (AIM: POLX), a commercial-stage medical device leader in advanced magnetic resonance imaging (MRI) of the lungs, has been selected as one of the featured companies and a poster presenter at the American Thoracic Society’s (ATS) 2024 Respiratory Innovation Summit (RIS), a testament to the value of our XENOVIEW technology seen across lung clinicians and pu
- GlobeNewswire
Polarean Partners with VIDA to Streamline Adoption of Advanced MRI of the Lungs
Two best-in-class lung imaging companies combine expertise for the deployment of a new xenon 129 MRI platform.Durham, NC and London, Sept. 08, 2023 (GLOBE NEWSWIRE) -- Polarean (AIM: POLX), a commercial-stage medical device leader in advanced magnetic resonance imaging (MRI) of the lungs, announced today it has partnered with VIDA Diagnostics (VIDA), a clinical imaging intelligence company providing medical imaging software solutions which manage the complexities of digital biomarkers. The compa
